By the Top Shelf Mushrooms Editorial Team | April 22, 2026
Commercial Disclosure: Top Shelf Mushrooms supports Pilly Labs as its commercial partner. This comparison is conducted using the same five-part evaluation framework applied to all content on this site. See our Research Standards & Disclosure for full details.
This article is for educational purposes only and does not constitute medical advice.
Multi-mushroom gummies have become one of the most competitive segments of the functional supplement market. Two products that appear in this category are Amvilab Mushroom Gummies (sold primarily through Amazon) and Pilly Labs Mushroom Gummies (Pilly Labs’ flagship multi-species product, available direct-to-consumer). Both are fruiting body gummy products. Both use 10:1 extract ratios. The differences that matter most are in how they approach dose transparency and label disclosure — which in turn determines how much a buyer can verify before purchasing.
This comparison covers both products on the five criteria this site uses for all supplement evaluations: sourcing, extraction, standardization, species selection, and label transparency.
Amvilab Mushroom Gummies: What the Label Shows
Amvilab’s formula is a 250mg Mushroom Extract Blend per serving across nine listed species — though Lion’s Mane appears twice (once as “Lion’s Mane Fruiting Body 10:1 Extract” and once as “Hericium erinaceus Fruiting Body 10:1 Extract,” which are the same species). The effective distinct species count is eight.
Sourcing: Fruiting body is specified for Shiitake, Lion’s Mane, Chaga, White Button Mushroom, Black Fungus, and Royal Sun Mushroom. Cordyceps is listed as “Cordyceps Extract” without a fruiting body or mycelium specification — the one open sourcing question in the formula.
Extraction: 10:1 ratios are specified for all species that include a sourcing specification. This is a positive quality indicator — 10:1 extract concentration is the standard for most quality functional mushroom supplements.
Standardization: Not disclosed on the label examined. Extract ratios are specified but standardized active compound content (such as beta-glucan percentage or polysaccharide percentage) is not stated.
Species selection: The eight distinct species map appropriately to the claimed brain, focus, and immune support applications. Lion’s Mane is the primary cognitive species; Turkey Tail and Chaga for immune support; Cordyceps for energy. White Button, Black Fungus, and Royal Sun Mushroom contribute beta-glucan content but have less differentiated research profiles.
Label transparency: Proprietary blend — per-species amounts not disclosed. At 250mg total across eight to nine species, the per-species average is approximately 28–31mg of extract (or approximately 280–310mg raw mushroom equivalent at 10:1). This is below the dosing ranges used in most published research on the primary species (Lion’s Mane cognitive research uses 500mg–3,000mg fruiting body equivalent; Cordyceps energy research uses 1,000mg–3,000mg). Whether the formula is weighted toward specific species cannot be confirmed without per-species disclosure.
For the full Amvilab product evaluation, see our complete Amvilab Mushroom Gummies review.
Pilly Labs Mushroom Gummies: What the Label Shows
Pilly Labs Mushroom Gummies are formulated by Pilly Labs as the flagship multi-species product in their functional mushroom lineup. The product is priced at $47.99 direct-to-consumer.
Sourcing: All ten species are specified as Fruiting Body sourcing — no mycelium-on-grain entries. This is the higher-quality sourcing standard across the formula without exception.
Extraction: 10:1 Extract ratios are specified per species across all ten species — consistent with the Amvilab approach on extraction processing quality.
Standardization: Per-species amounts are disclosed, which allows dose comparison against published research benchmarks. This is the defining transparency differentiator in this comparison.
Species selection: Ten species with direct relevance to the cognitive, immune, and energy support applications the product targets. The species selection covers the most research-developed functional mushrooms in the category.
Label transparency: Per-species disclosure — the key differentiator. Buyers can compare each species’ dose in the formula against published research dosing benchmarks, assess whether the formula is weighted toward species relevant to their specific goals, and make dose-informed purchasing decisions. For the full Pilly Labs evaluation including per-species dose analysis, see the Pilly Labs Mushroom Gummies review.
Side-by-Side: The Key Differences
On sourcing quality: both products use fruiting body sourcing and 10:1 extraction for their primary species. Amvilab’s Cordyceps sourcing is unspecified; Pilly Labs specifies fruiting body for all ten species. This is a genuine quality gap in the Amvilab label, not a cosmetic one — Cordyceps sourcing affects what bioactive compounds are actually present.
On dose transparency: Amvilab uses a proprietary blend; Pilly Labs discloses per-species amounts. For buyers who want to evaluate dose adequacy relative to research, only one of these label approaches enables that evaluation. For buyers purchasing based on brand trust rather than dose verification, this distinction matters less.
On standardization: Neither label explicitly claims polysaccharide or beta-glucan percentage standardization in the information available for this review. Extract ratios are the quality indicator both products use. Standardization claims would be an upgrade to both product disclosures.
On purchasing channel: Amvilab is available on Amazon at marketplace pricing; Pilly Labs is available direct-to-consumer at $47.99. Amazon marketplace pricing means price varies, return policy depends on whether Amazon or the third-party seller fulfills the order, and batch-to-batch consistency depends on the seller’s inventory practices.
Do Mushroom Gummies Use Fruiting Body or Mycelium?
This is the most important sourcing question in the functional mushroom supplement category, and the answer directly affects product quality. The distinction matters because fruiting body extracts — the actual mushroom cap and stalk — contain higher concentrations of beta-glucans, hericenones, and other bioactive compounds than mycelium-on-grain products, which are often high in starch from the grain substrate used to grow them.
For both Amvilab and Pilly Labs, fruiting body sourcing is specified for their primary species. Amvilab lists “Fruiting Body” for Lion’s Mane, Chaga, Shiitake, White Button, Black Fungus, and Royal Sun Mushroom — but leaves Cordyceps unspecified. Pilly Labs specifies fruiting body sourcing across all ten species without exception.
For a deeper explanation of what fruiting body vs. mycelium means for bioactive compound content and how to read supplement labels for this distinction, our guide to fruiting body vs. mycelium sourcing covers the research behind this difference in detail.
Decision Framework: Which Is Right for You
The right choice between these products depends on what you’re optimizing for:
If you have a specific cognitive, energy, or immune support goal and want to verify that the formula delivers research-relevant doses of the relevant species, Pilly Labs’ per-species disclosure lets you make that comparison; Amvilab’s proprietary blend does not.
If you’re new to functional mushrooms and looking for a broad-spectrum daily gummy to establish a habit without dose-specific targets, both products offer comparable extract quality (fruiting body, 10:1 ratios) in a palatable format. Amvilab’s Amazon availability offers convenience for buyers already purchasing through that channel.
If Cordyceps is a priority species in your formula — for energy or athletic performance — Amvilab’s unspecified Cordyceps sourcing is an unresolved question that Pilly Labs’ full fruiting body specification answers.
When None of These Gummies Are the Right Answer
Multi-species gummy formulas are optimized for daily convenience and broad-spectrum coverage. They’re not optimized for high-dose single-species targeting. If you’re specifically trying to replicate Lion’s Mane cognitive trial dosing (1,000mg+ fruiting body equivalent per day) or Cordyceps endurance dosing (1,500mg+), a single-species capsule or tincture format will deliver more per-serving dose efficiency at a comparable price point than any multi-species gummy.
For timing-sensitive applications — reishi for evening calm, cordyceps before a workout — tincture formats offer the flexibility that fixed-dose gummies don’t. Our supplement format guide covers the full format comparison including when gummies, capsules, and tinctures each make the most sense for specific applications. And for a practical guide to why mushroom supplements of any format may underperform expectations, see our dose transparency explainer.
Timeline Expectations for Any Multi-Mushroom Gummy
Regardless of which product you choose, functional mushroom adaptogens require consistent daily use over four to twelve weeks before measuring outcomes. Cognitive applications (Lion’s Mane) have shown effects in four-week trials at adequate doses. Stress and immune applications typically require six to twelve weeks. Products taken for one to two weeks and evaluated as “not working” have been evaluated on an insufficient timeline.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Top Shelf Mushrooms has a commercial relationship with Pilly Labs — this is disclosed above and in our Research Standards page. The evaluation framework applied to Pilly Labs products is identical to the framework applied to all content on this site. Supplement research referenced pertains to ingredients as studied in published scientific literature. These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any supplement.
Leave a Reply